ROIV 8-K: SEC filing
Roivant Sciences Ltd.
Filed with the SEC on · accession 0001635088-26-000130
ROIV filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Roivant Sciences Ltd. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
Key details
✦ Ask GOAX AI about this filing — what it means for ROIV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ROIV?
Click hereFrequently asked questions
What did ROIV file with the SEC on Nov 9, 2026?
ROIV filed a 8-K (SEC filing). Roivant Sciences Ltd. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ROIV SEC filings
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · Fda approvalOct 21, 2026
- 8-K · SEC filingSep 18, 2026
- 8-K · Fda approvalSep 8, 2026
- 8-K · Fda approvalAug 28, 2026
- 8-K · Fda approvalAug 27, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
Get alerts when ROIV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days